Showing results (551-560 of 600) with videos related to

Sort By:
Pageof 60
Cerebellum (London, England)|January 25, 2023
Two New Families and a Literature Review of ELOVL4-Associated Spinocerebellar Ataxia Type 34Masahiro Nishide, Kathleen Le Marquand, Mark R Davis, et al.
Journal of Extracellular Vesicles|March 26, 2025
Nanoscopic Profiling of Small Extracellular Vesicles via High-Speed Atomic Force Microscopy (HS-AFM) VideographyMuhammad Isman Sandira, Keesiang Lim, Takeshi Yoshida, et al.
European Heart Journal|May 2, 2009
MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenosesYoshinobu Onuma, Patrick Serruys, Peter den Heijer, et al.
Micromachines|November 27, 2021
Novel Platform for Regulation of Extracellular Vesicles and Metabolites Secretion from Cells Using a Multi-Linkable Horizontal Co-Culture PlateTakeo Shimasaki, Satoko Yamamoto, Risa Omura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 15, 2014
Glycine/Serine polymorphism at position 38 influences KCNE1 subunit's modulatory actions on rapid and slow delayed rectifier K+ currentsYoshiaki Yamaguchi, Kohki Nishide, Mario Kato, et al.
International Immunology|August 23, 2022
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosusAkiko Kajihara, Takayoshi Morita, Yasuhiro Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 3, 2020
[Tolerability of Definitive Chemoradiotherapy in Elderly Patients with Esophageal Cancer]Kaori Hino, Takeshi Kajiwara, Tomohiro Nishina, et al.
Nature Communications|October 11, 2023
Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitisMasayuki Nishide, Kei Nishimura, Hiroaki Matsushita, et al.
Modern Rheumatology|June 7, 2012
Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumabMie Fusama, Hideko Nakahara, Yoshimasa Hamano, et al.
Nature Immunology|May 20, 2018
Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarizationSujin Kang, Yoshimitsu Nakanishi, Yoshiyuki Kioi, et al.
Pageof 60